Table: Hisamitsu -Q1 group results

Hisamitsu Pharmaceutical Co

11/07/2024 07:00

Jul 11 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  May 31, 2024        May 31, 2023     Feb 28, 2025 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               35.81               32.10           152.00    
                   (+11.6 pct)         (+21.6 pct)      (+7.3 pct)  
  Operating            4.15                4.36            14.50    
                   (-4.9 pct)         (+739.1 pct)      (+10.1 pct) 
  Recurring            5.56                5.71            18.90    
                   (-2.7 pct)         (+148.6 pct)      (-3.8 pct)  
  Net                  4.79                4.05            15.80    
                   (+18.2 pct)        (+148.2 pct)      (+13.1 pct) 
  EPS               63.89 yen           52.09 yen       210.83 yen  
  EPS Diluted       63.82 yen           52.05 yen                   
  Ann Div                               85.00 yen        90.00 yen  
  -Q2 div                               42.50 yen        45.00 yen  
  -Q4 div                               42.50 yen        45.00 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T